Free Trial
Memorial Day Savings! Save $100 on MarketBeat All Access
Claim Your Discount
Claim MarketBeat All Access Sale Promotion

Qiagen (QGEN) Financials

Qiagen logo
$35.04 -0.05 (-0.15%)
As of 02:49 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare
Annual Income Statements for Qiagen

Annual Income Statements for Qiagen

This table shows Qiagen's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 130 80 40 190 -41 359 513 423 341 84 425
Consolidated Net Income / (Loss)		 130 80 40 190 -41 359 513 423 341 84 425
Net Income / (Loss) Continuing Operations		 130 80 40 190 -41 359 513 423 341 84 425
Total Pre-Tax Income 		136 57 114 226 -78 439 626 513 430 121 490
Total Operating Income		 179 99 153 267 -26 386 630 531 410 98 466
Total Gross Profit		 827 845 923 1,001 1,005 1,233 1,451 1,385 1,234 967 1,299
Total Revenue		 1,281 1,338 1,418 1,502 1,526 1,870 2,252 2,142 1,965 1,978 2,090
Operating Revenue		 1,281 1,338 1,418 1,502 1,526 1,870 2,252 2,142 1,965 1,978 2,090
Total Cost of Revenue		 454 493 495 501 521 638 801 757 732 1,011 791
Operating Cost of Revenue		 454 493 495 501 521 638 801 757 732 1,011 791
Total Operating Expenses		 647 746 769 734 1,031 846 821 853 824 870 834
Selling, General & Admin Expense		 - - 102 105 112 112 128 130 119 113 126
Marketing Expense		 360 376 376 392 392 414 456 474 460 451 458
Research & Development Expense		 147 150 154 162 157 149 190 190 199 193 188
Amortization Expense		 39 39 39 39 30 21 19 15 11 9.60 8.00
Restructuring Charge		 102 181 98 29 200 151 28 45 35 102 54
Total Other Income / (Expense), net		 -43 -42 -39 -41 -52 53 -4.25 -19 20 23 24
Interest Expense		 37 39 50 67 74 71 54 58 53 44 33
Interest & Investment Income		 4.75 6.78 11 21 22 10 9.56 33 79 68 64
Other Income / (Expense), net		 -11 -9.67 -0.00 5.60 0.43 114 41 6.74 -5.71 -0.74 -6.65
Income Tax Expense		 6.40 -23 74 35 -36 80 113 89 89 38 65
Basic Earnings per Share		 $0.56 $0.34 $0.18 $0.84 ($0.18) $1.57 $2.25 $1.86 $1.50 $0.38 $1.96
Weighted Average Basic Shares Outstanding		 233.48M 234.80M 228.07M 226.64M 226.78M 228.43M 227.98M 227.58M 228.15M 222.62M 217.22M
Diluted Earnings per Share		 $0.55 $0.34 $0.17 $0.82 ($0.18) $1.53 $2.21 $1.84 $1.48 $0.37 $1.94
Weighted Average Diluted Shares Outstanding		 238.65M 238.99M 233.01M 233.46M 226.78M 234.21M 232.03M 230.14M 230.62M 224.72M 218.88M
Weighted Average Basic & Diluted Shares Outstanding		 233.01M 234.56M 226.56M 225.51M 227.75M 227.99M 227.07M 227.72M 228.20M 222.29M 216.92M
Cash Dividends to Common per Share		 - - - - - - - - - - $0.25

Quarterly Income Statements for Qiagen

No quarterly income statements for Qiagen are available.

Annual Cash Flow Statements for Qiagen

This table details how cash moves in and out of Qiagen's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 -103 149 219 501 -530 -31 283 -150 -63 -4.53 175
Net Cash From Operating Activities		 317 342 287 359 331 458 639 715 459 674 654
Net Cash From Continuing Operating Activities		 317 342 287 359 331 458 639 715 459 674 654
Net Income / (Loss) Continuing Operations		 130 80 40 190 -41 359 513 423 341 84 425
Consolidated Net Income / (Loss)		 130 80 40 190 -41 359 513 423 341 84 425
Depreciation Expense		 191 213 216 206 231 205 215 208 205 203 194
Amortization Expense		 20 20 25 36 41 42 32 34 30 18 3.37
Non-Cash Adjustments To Reconcile Net Income		 42 90 36 46 210 -70 14 91 59 256 87
Changes in Operating Assets and Liabilities, net		 -66 -62 -31 -118 -110 -79 -135 -41 -176 112 -55
Net Cash From Investing Activities		 -146 -179 -464 -211 -222 -443 -202 -727 -88 -249 -305
Net Cash From Continuing Investing Activities		 -146 -179 -464 -211 -222 -443 -202 -727 -88 -249 -305
Purchase of Property, Plant & Equipment		 -98 -75 -90 -110 -118 -133 -190 -129 -150 -167 -201
Acquisitions		 -87 -110 -85 -214 -225 -411 -17 -84 -163 -4.07 -297
Purchase of Investments		 -324 -520 -455 -577 -294 -50 -400 -1,387 -979 -688 -372
Sale and/or Maturity of Investments		 368 534 189 692 391 207 360 883 1,271 585 597
Other Investing Activities, net		 -5.98 -8.80 -23 -19 23 -58 45 -9.77 -67 25 -32
Net Cash From Financing Activities		 -259 -11 387 360 -639 -50 -150 -126 -434 -423 -179
Net Cash From Continuing Financing Activities		 -259 -11 387 360 -639 -50 -150 -126 -434 -423 -179
Repayment of Debt		 -253 -18 140 486 -518 -365 -43 -480 -400 -602 -534
Repurchase of Common Equity		 -21 0.00 -61 -105 -74 -239 -100 0.00 0.00 -292 -280
Payment of Dividends		 - - - - - - - - 0.00 0.00 -54
Issuance of Debt		 1.59 0.00 330 0.00 0.00 557 0.00 371 0.00 494 742
Other Financing Activities, net		 3.33 0.78 -74 -97 -49 -11 -15 -17 -34 -23 -53
Effect of Exchange Rate Changes		 -15 -2.77 8.83 -7.18 0.83 4.20 -3.68 -13 -0.56 -5.96 5.38
Cash Interest Paid		 21 18 20 26 30 25 22 23 20 24 29
Cash Income Taxes Paid		 34 23 40 29 41 43 102 120 82 16 17

Quarterly Cash Flow Statements for Qiagen

No quarterly cash flow statements for Qiagen are available.

Annual Balance Sheets for Qiagen

This table presents Qiagen's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 4,179 4,308 5,039 5,748 5,264 5,928 6,147 6,288 6,115 5,690 6,281
Total Current Assets		 961 1,038 1,648 2,155 1,512 1,599 2,110 2,394 2,148 1,960 1,995
Cash & Equivalents		 290 439 658 1,159 622 597 881 731 668 664 839
Short-Term Investments		 131 93 359 235 108 14 185 688 390 489 260
Accounts Receivable		 274 278 329 352 376 381 362 324 382 349 403
Inventories, net		 137 137 156 163 171 291 328 358 398 279 302
Prepaid Expenses		 70 67 99 109 - - 355 294 310 178 192
Plant, Property, & Equipment, net		 443 437 494 512 356 427 638 662 765 754 924
Total Noncurrent Assets		 2,775 2,834 2,896 3,082 3,396 3,902 3,399 3,232 3,203 2,976 3,362
Goodwill		 1,876 1,926 2,013 2,109 2,166 2,389 2,351 2,353 2,476 2,425 2,701
Intangible Assets		 636 557 499 475 751 884 627 545 527 304 386
Other Noncurrent Operating Assets		 261 283 345 455 392 529 421 334 200 247 275
Total Liabilities & Shareholders' Equity		 4,179 4,308 5,039 5,748 5,264 5,928 6,147 6,288 6,115 5,690 6,281
Total Liabilities		 1,611 1,701 2,498 3,113 2,940 3,445 3,050 2,821 2,307 2,122 2,503
Total Current Liabilities		 268 308 325 972 951 571 1,517 975 1,079 1,042 512
Short-Term Debt		 - - 0.00 503 285 43 848 390 588 552 0.00
Accounts Payable		 52 51 59 69 85 118 101 99 84 83 73
Accrued Expenses		 192 230 242 263 - - 569 486 407 407 439
Total Noncurrent Liabilities		 1,343 1,393 2,173 2,141 1,989 2,874 1,533 1,847 1,228 1,080 1,991
Long-Term Debt		 1,049 1,067 1,758 1,671 1,419 1,875 1,094 1,472 922 840 1,654
Other Noncurrent Operating Liabilities		 224 285 338 407 542 953 439 375 306 241 337
Commitments & Contingencies		 0.00 0.00 0.00 0.00 - - 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 2,568 2,607 2,541 2,635 3,159 3,199 3,097 3,467 3,808 3,567 3,778
Total Preferred & Common Equity		 2,566 2,607 2,541 2,635 2.70 2.70 3,097 3,467 3,808 3,567 3,778
Total Common Equity		 2,566 2,607 2,541 2,635 1,368 1,359 3,097 3,467 3,808 3,567 3,778
Common Stock		 1,768 1,797 1,633 1,745 2.70 2.70 1,821 1,871 1,918 1,669 1,439
Retained Earnings		 1,209 1,263 1,248 1,380 948 998 1,792 2,160 2,457 2,448 2,748
Treasury Stock		 -152 -120 -119 -179 112 118 -190 -160 -133 -75 -32
Accumulated Other Comprehensive Income / (Loss)		 -259 -334 -221 -311 - - -327 -404 -434 -475 -377

Quarterly Balance Sheets for Qiagen

No quarterly balance sheets for Qiagen are available.

Annual Metrics And Ratios for Qiagen

This table displays calculated financial ratios and metrics derived from Qiagen's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 - - - - - - - - - - 216,920,735.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - - 216,920,735.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - - 1.96
Growth Metrics		 - - - - - - - - - - -
Profitability Metrics		 - - - - - - - - - - -
Net Operating Profit after Tax (NOPAT)		 171 139 54 225 -18 316 516 439 326 67 404
Return On Investment Capital (ROIC_SIMPLE)		 4.73% 3.80% 1.26% 4.68% -0.38% 6.17% 10.24% 8.24% 6.12% 1.36% 7.43%
Earnings before Interest and Taxes (EBIT)		 169 89 153 272 -26 501 671 538 404 97 459
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 380 323 395 514 247 748 918 780 640 319 656
Valuation Ratios		 - - - - - - - - - - -
Leverage & Solvency		 - - - - - - - - - - -
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 228 194 -86 92 222 -171 204 502 -24 521 -124
Efficiency Ratios		 - - - - - - - - - - -
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 3,196 3,142 3,282 3,415 3,175 3,661 3,973 3,910 4,260 3,806 4,334
Increase / (Decrease) in Invested Capital		 -57 -54 140 133 -241 487 312 -63 350 -454 528
Book Value per Share		 $11.06 $11.19 $10.83 $11.63 $6.07 $5.97 $13.58 $15.23 $16.72 $15.63 $17.00
Tangible Book Value per Share		 $0.23 $0.53 $0.12 $0.23 ($6.87) ($8.40) $0.52 $2.50 $3.54 $3.67 $3.11
Total Capital		 3,617 3,674 4,299 4,809 4,863 5,117 5,038 5,328 5,318 4,959 5,433
Total Debt		 1,049 1,067 1,758 2,174 1,704 1,918 1,942 1,861 1,510 1,392 1,654
Total Long-Term Debt		 1,049 1,067 1,758 1,671 1,419 1,875 1,094 1,472 922 1,338 1,654
Net Debt		 628 535 741 781 958 1,296 876 443 452 239 556
Capital Expenditures (CapEx)		 98 74 90 110 118 133 190 129 150 167 201
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 272 197 306 292 109 459 374 391 598 317 384
Debt-free Net Working Capital (DFNWC)		 693 729 1,323 1,686 846 1,070 1,440 1,809 1,656 1,470 1,483
Net Working Capital (NWC)		 693 729 1,323 1,183 560 1,028 592 1,419 1,068 1,416 1,483
Net Nonoperating Expense (NNE)		 41 59 14 34 23 -43 3.48 16 -16 -16 -21
Net Nonoperating Obligations (NNO)		 628 535 741 781 16 463 876 443 452 239 556
Total Depreciation and Amortization (D&A)		 211 234 241 242 272 247 247 242 235 222 197
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.57 $0.36 $0.19 $0.89 ($0.19) $0.00 $0.00 $1.97 $1.54 $0.38 $1.96
Adjusted Weighted Average Basic Shares Outstanding		 219.95M 221.43M 215.09M 213.73M 213.86M 0.00 0.00 214.62M 221.81M 222.62M 217.22M
Adjusted Diluted Earnings per Share		 $0.57 $0.36 $0.18 $0.87 ($0.19) $0.00 $0.00 $1.95 $1.52 $0.37 $1.94
Adjusted Weighted Average Diluted Shares Outstanding		 223.42M 225.38M 219.74M 220.16M 213.86M 0.00 0.00 217.03M 224.21M 224.72M 218.88M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 219.50M 221.20M 213.66M 212.67M 214.78M 0.00 0.00 214.75M 221.86M 222.29M 216.92M
Normalized Net Operating Profit after Tax (NOPAT)		 268 196 176 256 220 439 539 476 354 138 451
Debt Service Ratios		 - - - - - - - - - - -
Payout Ratios		 - - - - - - - - - - -

Quarterly Metrics And Ratios for Qiagen

No quarterly metrics and ratios for Qiagen are available.


Financials Breakdown Chart

Qiagen Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Qiagen's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Qiagen's net income appears to be on an upward trend, with a most recent value of $424.88 million in 2025, rising from $129.90 million in 2015. The previous period was $83.59 million in 2024. See Qiagen's forecast for analyst expectations on what's next for the company.

Qiagen's total operating income in 2025 was $465.85 million, based on the following breakdown:
  • Total Gross Profit: $1.30 billion
  • Total Operating Expenses: $833.64 million

Over the last 10 years, Qiagen's total revenue changed from $1.28 billion in 2015 to $2.09 billion in 2025, a change of 63.2%.

Qiagen's total liabilities were at $2.50 billion at the end of 2025, a 17.9% increase from 2024, and a 55.4% increase since 2015.

In the past 10 years, Qiagen's cash and equivalents has ranged from $290.01 million in 2015 to $1.16 billion in 2018, and is currently $839.01 million as of their latest financial filing in 2025.

Over the last 10 years, Qiagen's book value per share changed from 11.06 in 2015 to 17.00 in 2025, a change of 53.7%.


Related Companies

Financial statements for NYSE:QGEN last updated on 3/23/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Why this tiny stock may move before the SpaceX IPO drops
The projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...
Behind the Markets | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel